At the annual IDWeek meeting, Bruker announced the U.S. Food and Drug Administration (FDA) clearance of Claim 7 and Claim 8 for its MALDI Biotyper ® CA System, marking a significant advancement in ...
New nanoElute 2 features nano-LC advances, supports automated single cell sample preparation from label-free ProteoCHIP on CellenONE platform MetaboScape® 2023 advances fluxomics applications and ion ...
NEW YORK – With its recent investment in Munich-based diagnostics firm Recipe, Bruker aims to bring liquid chromatography-free mass spectrometry to the drug testing space. The company expects that ...
Announces majority investment in NGS bioinformatics solution provider Ridom GmbH New NGS microbiology solutions for hygiene testing and epidemiological studies HAI (Hospital-Acquired Infections) ...
Bruker has entered into a strategic collaboration for NGS bioinformatics applications in microbiology and infectious disease testing with Ridom GmbH, based in Muenster, Germany. Ridom´s NGS ...
A. Preview of timsTOF Ultra 2 system with novel Athena Ion Processor (AIP): - Improves protein group identification in single-cell proteomics (SCP) by 15%-20%, and ...
Bruker has formed a new, single division out of the various spatial biology assets it has acquired over the years. Now under a single operational banner, it includes the company’s previous Bruker ...
When NanoString Technologies—a pioneering spatial biology company in Seattle—filed for bankruptcy in February this year, the future of the company and its technology remained unknown. Although Joe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results